900120 — CXI Healthcare Technology Cashflow Statement
0.000.00%
Last trade - 00:00
- KR₩31bn
- -KR₩99bn
- CNY377.03m
- 49
- 100
- 24
- 63
2019 June 30th | 2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 June 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -425 | -580 | 29.7 | 32.2 | 39.6 |
Depreciation | |||||
Amortisation | |||||
Non-Cash Items | 65.8 | 231 | 3.57 | 9.43 | 1.63 |
Unusual Items | |||||
Equity in Net Earnings/Losses | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | 5.58 | 9.19 | -86.2 | 15.6 | 4.68 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Other Assets | |||||
Change in Accounts Payable | |||||
Change in Other Liabilities | |||||
Cash from Operating Activities | -345 | -261 | 49.9 | 187 | 175 |
Capital Expenditures | -0.244 | -387 | -1,172 | -0.03 | — |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | 119 | 911 | 1.89 | 0.759 | -0.14 |
Acquisition of Business | |||||
Sale/Maturity of Investment | |||||
Purchase of Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | 119 | 524 | -1,170 | 0.729 | -0.14 |
Financing Cash Flow Items | — | -0.04 | -0.015 | -0.025 | -0.015 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 5.13 | 4.09 | 4.25 | 6 | 8.04 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -222 | 266 | -1,116 | 193 | 182 |